Play store
A recent study in the United Kingdom has sparked global optimism, showing that girls vaccinated against HPV at ages 12–13 had nearly zero deaths from cervical cancer over the next 30 years.
In a historic milestone, England recorded no cervical cancer deaths among women aged 20–24 between 2020 and 2024—an achievement widely attributed to early HPV vaccination.
The findings offer renewed hope, particularly for countries like Bangladesh, where cervical cancer remains one of the leading causes of cancer-related deaths among women.
Cervical cancer is primarily caused by the Human Papillomavirus (HPV), with about 99.7% of cases linked to 13 high-risk strains.
Fortunately, safe and effective vaccines are now widely available to prevent HPV infection.
Health experts recommend vaccinating girls between the ages of 9 and 14—ideally before the onset of sexual activity—to significantly reduce future cancer risk.
Beyond cervical cancer, the vaccine also helps prevent cancers of the throat and mouth, as well as genital warts.
Bangladesh has already introduced HPV vaccination for adolescent girls through government programmes.
According to the World Health Organization (WHO), if 90% of girls worldwide are vaccinated before age 15—combined with regular screening—cervical cancer could be eliminated within the next century.
Vaccination before age 15 requires only a single dose, making it more cost-effective and easier to implement.
Despite its proven safety, some parents remain hesitant due to misconceptions.
Experts emphasise that side effects are generally mild, including slight pain at the injection site, redness, low-grade fever, or temporary body aches. Those with severe allergies should consult a doctor beforehand.
The HPV vaccination campaign among school-going girls in Bangladesh is expanding.
Health officials urge parents to vaccinate their daughters and help spread awareness, paving the way for a future free from cervical cancer.